Clinical Trials

195 results found

Prostate

NRG-GU011: A Phase II Double-Blinded, Placebo-Controlled Trial of Prostate Oligometastatic Radiotherapy with or...

This study focuses on individuals with prostate cancer. The purpose of the study is to evaluate whether a drug called relugolix plus the usual radiation therapy delays ...

Lung

S1800D: A Phase II/III Study of N-803 (ALT-803) plus Pembrolizumab versus Standard of...

Primary Objective: Patients will be enrolled into two cohorts defined as primary versus acquired resistance to prior anti-PD-(L)1 containing therapy (see Section 6.0). -The primary objective within the Primary Resistance Cohort is ...

Breast, Colon, Esophagus, Liver, Lung

IIT2021-07-ATKINS-CARMA: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Primary Objective: To measure adherence to cardio-oncology consultation Secondary Objectives To measure the rate of cardiovascular therapeutic medication intervention To measure the compliance rate of cardiovascular therapeutic medication intervention To ...

Lung

A021901: RANDOMIZED PHASE II TRIAL OF LUTETIUM LU 177 DOTATATE VERSUS EVEROLIMUS IN...

Primary Objective: -To compare progression-free survival (PFS) of receiving lutetium Lu 177 dotatate to that of receiving everolimus in patients with bronchial neuroendocrine tumor (NET) Secondary: -To compare the overall survival (OS) of ...

Cervix, Liver, Lung, Melanoma, Small Intestine, Stomach, Urinary Bladder

BA3071-001: A PHASE 1/2 STUDY OF BA3071 IN COMBINATION WITH NIVOLUMAB IN PATIENTS...

Phase 1 Objectives 2.1.1. Primary Objective To define the safety profile, including DLT, and determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of BA3071 when delivered ...